Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Ethan Hurwitz

5 papers in the library · 701 citations · publishing 2018-2022

Papers

Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT

PLoS One April 23, 2019 Roland R. Griffiths, Ethan Hurwitz, Alan K. Davis et al. 249 citations

Experiences interpreted as personal encounters with God, whether occurring naturally or after taking psychedelic drugs, share striking similarities. In an online survey of over 4,200 people, those who had a nondrug encounter most often called it God, whereas those who had a psychedelic encounter most often called it Ultimate Reality. Regardless of origin, most participants vividly remembered the encounter as involving a conscious, benevolent, intelligent, sacred, eternal, and all-knowing presence. About half of all encounters met criteria for a complete mystical experience. More than two-thirds of self-identified atheists no longer identified as atheist afterward.

Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects.

Journal of psychopharmacology (Oxford, England) September 1, 2020 Alan K. Davis, John Clifton, Eric G Weaver et al. 144 citations

Inhaling N,N-dimethyltryptamine (DMT) can trigger encounters with seemingly autonomous entities. A survey of 2,561 people (average age 32, 77% male) found that these encounters primarily involve visual and extrasensory perception, such as telepathy. Entities are most often described as beings, guides, spirits, aliens, or helpers. Although 41% of respondents felt fear, the dominant emotions were love, kindness, and joy, both in the respondent and attributed to the entity. Most believed the entity was conscious, intelligent, and benevolent, existing in a real but different dimension. 69% received a message, and 19% a prediction. Over half of those who were atheist before no longer identified as atheist afterward.

Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.

Psychopharmacology February 1, 2018 Theresa M. Carbonaro, Matthew W Johnson, Ethan Hurwitz et al. 139 citations

Psilocybin and dextromethorphan (DXM) both produce powerful subjective effects, but their experiences differ profoundly. In a double-blind comparison with 20 participants, high doses of both drugs caused similar overall drug effect strength and time-course. Psilocybin uniquely fostered richer, more complex visual experiences—including more movement, brightness, and kaleidoscopic imagery—along with greater mystical-type and psychologically insightful experiences and deeper music absorption. DXM, by contrast, produced stronger feelings of disembodiment, nausea, and light-headedness. Both drugs increased blood pressure, heart rate, and pupil dilation while impairing motor performance and balance.

Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.

Psychopharmacology October 1, 2018 Frederick S. Barrett, Theresa M. Carbonaro, Ethan Hurwitz et al. 109 citations

Classic psychedelics and dissociative hallucinogens may share some neuropsychological effects despite different pharmacology. In a double-blind, placebo-controlled study, 20 hallucinogen users received 10, 20, and 30 mg/70 kg psilocybin, 400 mg/70 kg dextromethorphan (DXM), and placebo across five sessions. Neither drug caused global cognitive impairment. Psilocybin produced dose-dependent effects on psychomotor performance, working memory, episodic memory, associative learning, and visual perception. DXM affected psychomotor performance, visual perception, and associative learning similarly to moderate-to-high psilocybin doses. Psilocybin affected working memory more than DXM, while DXM had greater effects on balance, episodic memory, response inhibition, and executive control.

Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying

PLoS One August 24, 2022 Mary M. Sweeney, Sandeep M. Nayak, Ethan Hurwitz et al. 60 citations

Psychedelic drug experiences and near-death or other non-ordinary experiences both change people's beliefs about death, but direct comparisons are rare. In a survey of 3,192 individuals who reported such experiences, those from non-drug causes (e.g., near-death) were more likely to involve unconsciousness, clinical death, or imminent danger. Both groups reported similar reductions in fear of death, high personal meaning, spiritual significance, and psychological insight. However, psychedelic participants scored higher on standardized measures of mystical and near-death features, while non-drug participants more often rated their experience as the single most meaningful of their lives. Among psychedelics, ayahuasca and DMT produced stronger positive enduring effects than psilocybin and LSD.